Avance Biosciences specializes in assay development, validation, and sample testing services supporting our clients for their drug development initiatives and GMP manufacturing activities. We are a leader in applying state-of-art technologies, such as next generation sequencing (NGS) and digital droplet PCR (ddPCR), to improve the effectiveness and efficiency of biologic tests.
Onco Cell Therapy Summit (OCTS), formerly the CAR-T Congress, is an event that brings industry together to share novel research, manufacturing techniques and regulatory best practice. Each session of OCTS 2020 is dedicated to translating your novel data assets & IP into commercially viable oncological therapies.
OCTS is a 4-track event and whilst bringing together the key decision makers for CAR-T therapies, this year’s event will have an added focus on the ground breaking science that is driving the surge of interest in harnessing alternative cell therapies in cancer treatments.
CAR-T R&D
Alternative Cell Therapies
Vein-to-Vein Commercialization
Regulation and Safety
Avance offers cell therapy genomic testing services supporting CAR/TCR development and manufacturing
Avance Biosciences provides assay development, validation and sample testing services for lot release of manufactured T-cells and for monitoring copy number of target genes in patients’ blood during clinical trials.